| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SRRK sits in the Biotechnology industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.60M | - | - | |
| Pres | 595.8K | $25.44M | - | |
| CFO | 583.2K | $24.90M | - | |
| COO | 572.0K | - | - | |
| Other | 241.5K | $11.24M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul 1, 2026 | Peng Katie | Director | Sell | 5,446 | $53.88 | $293,404.51 | -13.7% | - | - | |
| Jul 1, 2026 | Reed Joshua | Director | Sell | 3,053 | $53.74 | $164,067.43 | -13.5% | - | - | |
| Jul 1, 2026 | Gilman Michael | Director | Sell | 2,544 | $53.87 | $137,057.93 | -4.1% | - | - | |
| Jul 1, 2026 | Flier Jeffrey S.57 | Director | Sell | 3,053 | $53.88 | $164,490.22 | -9.9% | - | - | |
| Jul 1, 2026 | Burow Kristina66 | Director | Sell | 3,053 | $53.74 | $164,063.83 | -2.6% | - | - | |
| Apr 16, 2026 | Woods Keith | Chief Operating Officer | Sell | 10,220 | $49.57 | $506,651.39 | -1.6% | +8.1% | - | |
| Feb 17, 2026 | Parlavecchio Caryn | CHRO | Sell | 9,035 | $46.53 | $420,382.29 | -5.1% | +6.2% | - | |
| Feb 17, 2026 | Qatanani Mo | Chief Scientific Officer | Sell | 7,989 | $46.53 | $371,713.79 | -7.0% | +6.2% | - | |
| Feb 17, 2026 | Ho Junlin | General Counsel | Sell | 9,580 | $46.53 | $445,740.16 | -3.8% | +6.2% | - | |
| Feb 17, 2026 | Marantz Jing L. | Chief Medical Officer | Sell | 4,157 | $46.53 | $193,417.73 | -3.2% | +6.2% | - |